Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts: A Feasibility Study in Swedish Psychiatric Inpatient Care
BCBT
2 other identifiers
interventional
32
0 countries
N/A
Brief Summary
The goal of this study is to determine whether Brief Cognitive Behaviour Therapy (BCBT), a four-session psychological treatment aimed at reducing suicide attempts, is acceptable and feasible to deliver during psychiatric inpatient care for adults who have been hospitalised following a suicide attempt or who are at high risk of suicide. The main questions it aims to answer are:
- Receive four structured BCBT therapy sessions delivered during hospitalisation, in addition to usual care
- Be contacted for follow-up assessments at 1 and 3 months after completing treatment
- Take part in an interview about the participants' experience with the treatment 1 month after completing it Clinical staff, treating psychologists, and managers will also be interviewed to explore the participants' experiences, as well as barriers and facilitators to implementation. Overall, the findings from this study will inform the design of a future randomised trial to test the effectiveness of BCBT in reducing suicide attempts after discharge from inpatient psychiatric care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2026
CompletedStudy Start
First participant enrolled
April 27, 2026
CompletedFirst Posted
Study publicly available on registry
May 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 14, 2027
May 5, 2026
April 1, 2026
8 months
April 20, 2026
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Treatment completion
Proportion of participants completing 3 or more BCBT sessions
Posttreatment assessment performed within two working days after the final treatment session.
Treatment satisfaction
Patient-reported treatment satisfaction assessed using the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item scale, with each item rated on a four-point Likert scale (1-4), giving a total score ranging from 8 to 32, with higher scores indicating greater treatment satisfaction.
Posttreatment assessment performed within two working days after the final treatment session.
Retention
Proportion of participants completing follow-up assessments at 1 and 3 months
1- and 3-month follow-up after the final treatment session
Secondary Outcomes (9)
Decline rate
From first potentially eligible participant approached until recruitment of 20 patients is completed (anticipated duration: 6 months)
Recruitment pace
From first potentially eligible participant approached until recruitment of 20 patients is completed (anticipated duration: 6 months)
Likelihood of treatment component use
During the 4-session treatment period (planned for 4 consecutive days), assessed at each session
Use and perceived helpfulness of treatment components
1- and 3-month follow-up after the final treatment session
Adverse events and negative effects of treatment
During the 4-session treatment period (planned for 4 consecutive days), assessed at each session; posttreatment assessment (performed within 2 working days after the final treatment session); and 1- and 3-month follow-up after the final treatment session
- +4 more secondary outcomes
Study Arms (1)
BCBT
EXPERIMENTALParticipants will receive four individual BCBT sessions delivered by trained clinical psychologists during their inpatient stay. Each session lasts approximately 60-90 minutes and focuses on specific therapeutic components. The first session includes psychoeducation, a narrative of the suicide attempt, and development of an individualised case conceptualisation and safety plan. The second session focuses on cognitive flexibility and identifying reasons for living, including the creation of a "hope box". The third session addresses restriction of access to lethal means and development of coping strategies, including coping cards. The fourth session focuses on consolidation of skills and relapse prevention, including guided imagery exercises to prepare for future crises. If discharge occurs before completion, sessions may be continued after discharge.
Interventions
Brief Cognitive Behaviour Therapy to prevent suicide reattempts
Eligibility Criteria
You may qualify if:
- admitted following a suicide attempt within one week of admission or presenting with suicidal ideation with a plan and a prior suicide attempt within the last two years
- years or older
You may not qualify if:
- current mania, current acute psychosis, or cognitive impairment
- expected inpatient stay shorter than four working days
- ongoing or planned electroconvulsive therapy
- psychiatric or somatic conditions leading to inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Stockholmcollaborator
- Karolinska Institutetlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 20, 2026
First Posted
May 5, 2026
Study Start
April 27, 2026
Primary Completion (Estimated)
December 14, 2026
Study Completion (Estimated)
December 14, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share